Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fulvestrant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02389842
What this trial is testing

PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib

Who this might be right for
Advanced Solid TumoursBreast Cancer
Royal Marsden NHS Foundation Trust 79
Early research (Phase 1)Active Not RecruitingNCT07557004
What this trial is testing

SH3765 Tablets in Combination With Fulvestrant in Patients With HR+/HER2- Advanced Breast Cancer.

Who this might be right for
HR+ / HER2- Advanced Breast Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105632
What this trial is testing

Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

Who this might be right for
Advanced or Metastatic Breast Cancer
Pfizer 333
Testing effectiveness (Phase 2)UnknownNCT02072512
What this trial is testing

The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hospital Affiliated to Military Medical Science, Beijing 180
Testing effectiveness (Phase 2)Study completedNCT00082810
What this trial is testing

Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerRecurrent Breast CancerStage IIIB Breast Cancer+2 more
National Cancer Institute (NCI) 33
Not applicableEnded earlyNCT00241462
What this trial is testing

Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients

Who this might be right for
Breast Cancer
AstraZeneca 150
Early research (Phase 1)Study completedNCT02260661
What this trial is testing

Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid MalignanciesBreast Cancer - ER+, HER2 -Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation
AstraZeneca 20
Testing effectiveness (Phase 2)Ended earlyNCT01233947
What this trial is testing

Study of AFP464 +/- Faslodex in ER + Breast Cancer

Who this might be right for
Breast Neoplasm
Tigris Pharmaceuticals 7
Testing effectiveness (Phase 2)Ended earlyNCT03322215
What this trial is testing

HR+/HER2- Advanced Breast Cancer and Endocrine Resistance

Who this might be right for
Breast Cancer Metastatic
Theodoros Foukakis 42
Large-scale testing (Phase 3)Active Not RecruitingNCT05654623
What this trial is testing

Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

Who this might be right for
Advanced Breast Cancer
Pfizer 624
Early research (Phase 1)Looking for participantsNCT07540572
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Who this might be right for
ER+, HER 2- Breast CancerNon-small Cell Lung Cancer (NSCLC)Castration-resistant Prostate Cancer (CRPC)+1 more
IDEAYA Biosciences 160
Testing effectiveness (Phase 2)Temporarily pausedNCT00738777
What this trial is testing

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 250
Not applicableUnknownNCT04526028
What this trial is testing

Palbociclib in Combination With Fulvestrant Versus Fulvestrant in Advanced Breast Cancer: A Real-world Study in China

Who this might be right for
Breast CancerFulvestrantPalbociclib
Tianjin Medical University Cancer Institute and Hospital 612
Testing effectiveness (Phase 2)Study completedNCT01556191
What this trial is testing

Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR

Who this might be right for
Stage IV Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 379
Testing effectiveness (Phase 2)Study completedNCT02491983
What this trial is testing

Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
MedSIR 486
Large-scale testing (Phase 3)UnknownNCT02394496
What this trial is testing

Overcoming Endocrine Resistance in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Consorzio Oncotech 396
Testing effectiveness (Phase 2)Study completedNCT02137083
What this trial is testing

A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 22
Testing effectiveness (Phase 2)Ended earlyNCT02569801
What this trial is testing

GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) Therapy

Who this might be right for
Breast Cancer
Genentech, Inc. 71
Large-scale testing (Phase 3)Study completedNCT01942135
What this trial is testing

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

Who this might be right for
Metastatic Breast Cancer
Pfizer 521
Not applicableUnknownNCT05140655
What this trial is testing

Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

Who this might be right for
Breast Neoplasm Female
Dr. Reddy's Laboratories SAS 40
Next Page